← FDA Drug Approvals (Drugs@FDA)
POMALIDOMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMACEUTICAL INDUSTRIES LIMITED · Approved 2026-03-24
Drug application
- FDA Application #
ANDA210232- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POMALIDOMIDE
- Generic name
- Pomalidomide
- Active ingredients
- POMALIDOMIDE
- Dosage form
- CAPSULE
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- SUN PHARMACEUTICAL INDUSTRIES LIMITED
- First approval
- 2026-03-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown